TITLE

Enterovesical Fistula Complicating Crohn's Ileocolitis

AUTHOR(S)
Schraut, Wolfgang H.; Block, George E.
PUB. DATE
March 1984
SOURCE
American Journal of Gastroenterology;Mar1984, Vol. 79 Issue 3, p186
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
An enterovesical fistula, an infrequent complication of Crohn's ileocolitis which is considered to constitute a difficult surgical problem, was encountered in 29 patients. These patients had been treated for Crohn's disease by medical means for years and several had previously undergone bowel resections. An exacerbation of the Crohn's disease occurred in all patients coincident with the appearance of dysuria or the obvious clinical presentation (fecaluria) of the fistula. Other manifestations of active Crohn's disease frequently coexisted. Radiographic evaluation was of limited help in establishing the presence of the fistula. Cystoscopy was suggestive of the diagnosis in 18 of 20 patients so examined. Treatment consisted of ileocecal resection with primary anastomosis (25) or exteriorization (4). The bladder defect was sparingly excised and closed with absorbable sutures. One patient developed a bladder leak which closed spontaneously. Recovery was uneventful in the others. An ileovesical fistula constitutes an indication for operation not only to erradicate the urinary sepsis but also to correct the other complications (malnutrition, obstruction, abscess) of Crohn's disease. To assure an uncomplicated course, emphasis must be placed on an individually designed correct approach to the (causative) intestinal problem, while the surgical aspects of the bladder defect can be a matter of routine.
ACCESSION #
16241734

 

Related Articles

  • GENETIC ANTICIPATION IN CROHN'S DISEASE. Bayless, Theodore M.; Picco, Michael F.; LaBuda, Michele C. // American Journal of Gastroenterology;Dec1998, Vol. 93 Issue 12, p2322 

    Discusses research being done on genetic anticipation in Crohn's disease. Reference to a study led by D. Heresbach, B. Gulwani-Akolkar and M. Lesser, which appeared in the 1998 issue of the "American Journal of Gastroenterology"; Potential biases that could influence the age at a diagnosis in...

  • COLOBRONCHIAL FISTULA: AN UNUSUAL COMPLICATION OF CROHN'S DISEASE. Singh, Daljit; Cole, Jack C.; Cali, Rebecca L.; Finical, Eric J.; Proctor, Deborah D. // American Journal of Gastroenterology;Dec1994, Vol. 89 Issue 12, p2250 

    Fistulas secondary to Crohn's disease occur in about 33% of patients. A colobronchial fistula complicating Crohn's disease is very rare, having been reported only twice previously. We present an unusual Fistula secondary to Crohn's colitis that originated from the splenic flexure and crossed the...

  • Type of Fistula Determines Response to Infliximab in Patients with Fistulous Crohn's Disease. Parsi, Mansour A.; Lashner, Bret A.; Achkar, Jean-Paul; Connor, Jason T.; Brzezinski, Aaron // American Journal of Gastroenterology;Mar2004, Vol. 99 Issue 3, p445 

    OBJECTIVES: Infliximab has been shown to be efficacious for treating perianal fistulae in patients with Crohn's disease. There is limited information regarding response to infliximab in patients with other types of fistulae.METHODS: Sixty consecutive patients with fistulous Crohn's disease and...

  • Methotrexate Following Unsuccessful Thiopurine Therapy in Pediatric Crohn's Disease. Turner, Dan; Grossman, Andrew B.; Rosh, Joel; Kugathasan, Subra; Gilman, Ashley R.; Baldassano, Robert; Griffiths, Anne M. // American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2804 

    BACKGROUND: The thiopurines, azathioprine and 6-mercaptopurine, are traditional first-line immunomodulatory agents in adult and pediatric Crohn's disease, but the comparative efficacy and safety of methotrexate have seldom been examined. We report outcomes with methotrexate treatment in...

  • Preventing postsurgical relapse of Crohn's disease: can we do better?  // Gut;Jan2009, Vol. 58 Issue 1, p126 

    The article presents author's view on the study on the effectiveness of the therapy to prevent postoperative recurrence of Crohn's disease. The author relates that the primary outcome of endoscopic neoterminal ileal recurrence was observed in 55% on azathioprine or placebo for 12 months. Results...

  • Gastrocolic fistulization in crohn's disease: A case report and a review of the literature. Khanna, M. Priya; Gordon, Philip H. // Canadian Journal of Surgery;Feb2000, Vol. 43 Issue 1, p53 

    Presents a case report on gastrocolic fistulization in Crohn's disease. Patient characteristics; Symptoms; Treatment and outcome of patients in reported series of gastrocolic fistula in Crohn's disease.

  • Rectouterine fistulation in Crohn's disease. Stoddard, C.J.; Irvin, T.T. // British Medical Journal;6/18/1977, Vol. 1 Issue 6076, p1574 

    Presents a case of young woman having Crohn's disease complicated with rectouterine fistulation. Medical history of the young woman; Diagnosis of the disease; Effects of the proximity of the sigmoid colon and rectum to the vagina on the incidence of rectovaginal fistulae.

  • Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease Van Assche, Gert; Vanbeckevoort, Dirk; Bielen, Didier; Coremans, Georges; Aerden, Isolde; Noman, Maya; D’Hoore, Andre; Penninckx, Freddy; Marchal, Guy; Cornillie, Freddy; Rutgeerts, Paul // American Journal of Gastroenterology;Feb2003, Vol. 98 Issue 2, p332 

    : ObjectivesAlthough the clinical efficacy of infliximab as measured by closure of fistulas in Crohn’s disease has been demonstrated, its influence on the inflammatory changes in the fistula tracks is less clear. The aim of the present study was to assess the behavior of perianal fistulas...

  • Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn’s disease Ochsenkühn, Thomas; Göke, Burkhard; Sackmann, Michael // American Journal of Gastroenterology;Aug2002, Vol. 97 Issue 8, p2022 

    OBJECTIVES:Fistulas occur in about one third of patients with Crohn’s disease and rarely heal spontaneously. Conventional medical and surgical therapy often fails. The anti-TNF-α antibody infliximab offers a novel therapeutic option. By this approach, closure of fistulas was reported...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics